ETF Managers Group, LLC Vbi Vaccines Inc Transaction History

ETF Managers Group, LLC

$2.78 Billion
Q1 2023

A detailed history of ETF Managers Group, LLC transactions in Vbi Vaccines Inc stock. As of the latest transaction made, ETF Managers Group, LLC holds 85,744 shares of VBIV stock, worth $1,714. This represents 0.0% of its overall portfolio holdings.

Number of Shares

85,744

Previous 64,387 33.17%

Holding current value

$1,714

Previous $25,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	BUY	$0.29 - $0.64 $6,193 - $13,668	21,357 Added 33.17%	85,744 $25,000
Q4 2022 Mar 23, 2023	SELL	$0.38 - $22.5 $4,492 - $266,017	-11,823 Reduced 15.51%	64,387 $25,000
Q3 2022 Nov 14, 2022	SELL	$0.73 - $23.4 $3,928 - $125,938	-5,382 Reduced 6.6%	76,210 $54,000
Q2 2022 Aug 15, 2022	BUY	$0.66 - $1.81 $2,339 - $6,414	3,544 Added 4.54%	81,592 $67,000
Q1 2022 May 13, 2022	BUY	$1.27 - $2.47 $323 - $629	255 Added 0.33%	78,048 $130,000
Q4 2021 Feb 14, 2022	SELL	$2.21 - $3.22 $19,587 - $28,538	-8,863 Reduced 10.23%	77,793 $187,000
Q3 2021 Nov 15, 2021	SELL	$2.8 - $3.72 $177,209 - $235,435	-63,289 Reduced 42.21%	86,656 $268,000
Q2 2021 Aug 16, 2021	SELL	$2.61 - $4.17 $14,887 - $23,785	-5,704 Reduced 3.66%	149,945 $558,000
Q1 2021 May 17, 2021	SELL	$2.91 - $4.32 $232,264 - $344,805	-79,816 Reduced 33.9%	155,649 $459,000
Q4 2020 Feb 16, 2021	SELL	$2.15 - $3.5 $53,089 - $86,425	-24,693 Reduced 9.49%	235,465 $711,000
Q3 2020 Nov 16, 2020	BUY	$2.77 - $6.17 $533,828 - $1.19 Million	192,718 Added 285.76%	260,158 $775,000
Q2 2020 Aug 14, 2020	BUY	$0.87 - $3.13 $58,672 - $211,087	67,440 New	67,440 $211,000

Others Institutions Holding VBIV

# of Institutions

Shares Held

688K

Call Options Held

Put Options Held

Frontier Wealth Management LLC Kansas City, MO

602K
Shares

$12,036
0.01% of portfolio

View Full List

About VBI Vaccines Inc

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

More about VBIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.

Account

ETF Managers Group, LLC Vbi Vaccines Inc Transaction History